Empagliflozin 20 mg
DEMETER
Phase 3 small_molecule active
Quick answer
Empagliflozin 20 mg for Metabolic Syndrome is a Phase 3 program (small_molecule) at COLLEGIUM PHARMACEUTICAL, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- COLLEGIUM PHARMACEUTICAL, INC
- Indication
- Metabolic Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active